Bought
Maintained
Sold
Other funds holding AMGN
INVST's AMGN Position: Q2 2026 in Review
INVST reduced its Amgen (AMGN) stake by 1.2% in Q2 2026, selling an estimated $3.08K and leaving 742 shares worth $269K. The position accounts for 0.03% of the portfolio, ranked #309.
INVST first reported a position in AMGN in Q1 2020 and has held it in 21 quarters since. The position peaked at $1.01M in Q2 2024. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- INVST held 742 shares of Amgen worth $269K as of Q2 2026.
- INVST sold 9 Amgen shares in Q2 2026, an estimated $3.08K.
- Amgen made up 0.03% of INVST's portfolio in Q2 2026, its #309 holding.
- INVST first reported a position in Amgen in Q1 2020 and has held it in 21 quarters since.
- INVST's Amgen position peaked at $1.01M in Q2 2024.
- 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on INVST's 13F filing for Q2 2026, filed 14 Aug 2026.